Company / Current Liabilities per Share
Ligand Pharmaceuticals, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.96
FY2025
5-year range
$0.99 / $5.89
FY2021-FY2025
Trend
-7.3%
vs FY2024
Sector context
#67 of 210
Health Care
What the data says
At $1.96, Ligand Pharmaceuticals, Inc.'s current liabilities per share ranks #144 of 210 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.82 in FY2019 to $11.42 in FY2017.
Based on SEC 10-K filings.
1.96 in FY2025 with a 5-year CAGR of -19.9%.
Increased from $0.99 to $1.96 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -30.7%
- 5-Year CAGR
- -19.9%
- 10-Year CAGR
- -
Sector benchmark
-91.8% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 7.3% year-over-year.
- Ranks #67 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2017.
- Lowest current liabilities per share in the period was in FY2019.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.96 | -7.3% |
| FY2024 | $2.11 | +113.5% |
| FY2023 | $0.99 | -83.2% |
| FY2022 | $5.89 | +127.4% |
| FY2021 | $2.59 | -56.5% |
| FY2020 | $5.95 | +626.8% |
| FY2019 | $0.82 | -78.9% |
| FY2018 | $3.89 | -66.0% |
| FY2017 | $11.42 | +0.3% |
| FY2016 | $11.39 | +0.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026